111 related articles for article (PubMed ID: 26456863)
1. Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.
Lajmi N; Luetkens T; Yousef S; Templin J; Cao Y; Hildebrandt Y; Bartels K; Kröger N; Atanackovic D
Br J Haematol; 2015 Dec; 171(5):752-62. PubMed ID: 26456863
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
Atanackovic D; Hildebrandt Y; Jadczak A; Cao Y; Luetkens T; Meyer S; Kobold S; Bartels K; Pabst C; Lajmi N; Gordic M; Stahl T; Zander AR; Bokemeyer C; Kröger N
Haematologica; 2010 May; 95(5):785-93. PubMed ID: 20015885
[TBL] [Abstract][Full Text] [Related]
3. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
Song X; Guo C; Zheng Y; Wang Y; Jin Z; Yin Y
BMC Cancer; 2018 Oct; 18(1):971. PubMed ID: 30309319
[TBL] [Abstract][Full Text] [Related]
5. Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.
Wang J; Song X; Guo C; Wang Y; Yin Y
Cancer Sci; 2016 Dec; 107(12):1888-1897. PubMed ID: 27636589
[TBL] [Abstract][Full Text] [Related]
6. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells.
Tseng HY; Chen LH; Ye Y; Tay KH; Jiang CC; Guo ST; Jin L; Hersey P; Zhang XD
Carcinogenesis; 2012 Oct; 33(10):1871-81. PubMed ID: 22791814
[TBL] [Abstract][Full Text] [Related]
7. Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.
Yang B; O'Herrin S; Wu J; Reagan-Shaw S; Ma Y; Nihal M; Longley BJ
J Invest Dermatol; 2007 Feb; 127(2):267-75. PubMed ID: 16960553
[TBL] [Abstract][Full Text] [Related]
8. The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.
Song X; Hao J; Wang J; Guo C; Wang Y; He Q; Tang H; Qin X; Li Y; Zhang Y; Yin Y
Oncogene; 2017 Mar; 36(11):1476-1486. PubMed ID: 27775077
[TBL] [Abstract][Full Text] [Related]
9. MageC2 protein is upregulated by oncogenic activation of MAPK pathway and causes impairment of the p53 transactivation function.
Pascucci FA; Ladelfa MF; Toledo MF; Escalada M; Suberbordes M; Monte M
Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118918. PubMed ID: 33279609
[TBL] [Abstract][Full Text] [Related]
10. Significant impact of survivin on myeloma cell growth.
Romagnoli M; Trichet V; David C; Clément M; Moreau P; Bataille R; Barillé-Nion S
Leukemia; 2007 May; 21(5):1070-8. PubMed ID: 17315024
[TBL] [Abstract][Full Text] [Related]
11. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Atanackovic D; Luetkens T; Hildebrandt Y; Arfsten J; Bartels K; Horn C; Stahl T; Cao Y; Zander AR; Bokemeyer C; Kröger N
Clin Cancer Res; 2009 Feb; 15(4):1343-52. PubMed ID: 19190130
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of c-Met inhibits cell proliferation and invasion and increases chemosensitivity to doxorubicin in human multiple myeloma U266 cells in vitro.
Que W; Chen J
Mol Med Rep; 2011; 4(2):343-9. PubMed ID: 21468575
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
17. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis.
Peikert T; Specks U; Farver C; Erzurum SC; Comhair SA
Cancer Res; 2006 May; 66(9):4693-700. PubMed ID: 16651421
[TBL] [Abstract][Full Text] [Related]
18. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells.
Lechler P; Schaumburger J; Köck FX; Balakrishnan S; Doukas S; Prantl L; Grifka J
Calcif Tissue Int; 2011 Sep; 89(3):211-20. PubMed ID: 21674243
[TBL] [Abstract][Full Text] [Related]
19. Cancer‑testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells.
Zeng P; Wang Y; Zheng Y; Song X; Yin Y
Mol Med Rep; 2018 Feb; 17(2):3226-3231. PubMed ID: 29257297
[TBL] [Abstract][Full Text] [Related]
20. RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
Liu H; Ding L; Shen Y; Zhong F; Wang Q; Xu X
Int J Biol Macromol; 2016 Oct; 91():115-22. PubMed ID: 27189701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
